SBIR-STTR Award

Secure, Miniature, Algorithm-enhanced Low-power Low-profile Photoplethysmogram Patch
Award last edited on: 2/19/2024

Sponsored Program
SBIR
Awarding Agency
DOD : Army
Total Award Amount
$1,099,998
Award Phase
2
Solicitation Topic Code
A16-053
Principal Investigator
John Bell

Company Information

Physical Optics Corporation (AKA: POC~Mercury Mission Systems, LLC)

1845 West 205th Street
Torrance, CA 90501
   (310) 320-3088
   info@pocsports.com
   www.poc.com
Location: Multiple
Congr. District: 43
County: Los Angeles

Phase I

Contract Number: 2017
Start Date: ----    Completed: 00/00/00
Phase I year
2016
Phase I Amount
$100,000
No abstract available.

Phase II

Contract Number: N/A
Start Date: 00/00/00    Completed: 7/14/2017
Phase II year
2017
(last award dollars: 1708356031)
Phase II Amount
$999,998

To address the Army’s need for a secure disposable patch that generates a photoplethysmogram (PPG) waveform, Physical Optics Corporation (POC) proposes to continue the development of a new ruggedized Secure, Miniature, Algorithm-Enhanced Low-Power Low-Profile Photoplethysmogram (SMALL-PPG) patch proven feasible in Phase I. SMALL-PPG is based on a novel integration of POC’s physiological monitoring technology, miniaturized electronics and sensors, patient status algorithms, and wireless interface. Specifically, the innovation in electronics miniaturization, signal processing algorithms, and reflective PPG configuration enables the patch to measure and transmit a PPG waveform to an end-user device (EUD) for additional analysis and provide patient status remotely. Building on POC’s previous successes in wearable electronics and physiological sensors, POC successfully researched, designed, and demonstrated a prototype in Phase I that can wirelessly transmit data to an EUD. The prototype generates a high-accuracy PPG waveform and derives physiological parameters in real time and is ready for initial testing in the Phase I Option. In Phase II, POC will develop a ruggedized SMALL-PPG prototype that can be demonstrated in a field environment with soldier medical attendants. Collaboration with military end-users will result in transition of the SMALL-PPG technology proof-of-concept evaluations in Phase III.